Literature DB >> 28451877

Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence.

Martin Robert Grübler1,2, Winfried März3,4,5, Stefan Pilz6,7, Tanja B Grammer8, Christian Trummer6, Christian Müllner6, Verena Schwetz6, Marlene Pandis6, Nicolas Verheyen9, Andreas Tomaschitz9,10, Antonella Fiordelisi11, Daniela Laudisio11, Ersilia Cipolletta12, Guido Iaccarino12.   

Abstract

Vitamin D has long been established as an elemental factor of bone physiology. Beyond mineral metabolism, the expression of the vitamin D receptor has been identified throughout the cardiovascular (CV) system. Experimental studies showed beneficial effects of vitamin D on heart and vessels, but vitamin D intoxication in animals also led to hypercalcemia and vascular calcification. Our knowledge has been extended by epidemiological studies that showed that 25-hydroxyvitamin D (25(OH)D) levels are inversely associated with an increased CV risk itself, but also with established CV risk factors, such as arterial hypertension, endothelial dysfunction and atherosclerosis. Conversely, randomized controlled trials could not document significant and consistent effects of vitamin D supplementation on CV risk or events. Potential explanations may lie in differences in reference ranges or the possibility that low vitamin D in CV disease is only an epiphenomenon. In the latter case, the key question is why low 25(OH)D levels are such a strong predictor of health. While we wait for new data, the current conclusion is that vitamin D is a strong risk marker for CV risk factors and for CV diseases itself.

Entities:  

Keywords:  Cardiovascular; Cardiovascular risk; Epidemiology; Mortality; Review; Vitamin D; Vitamin D receptor

Mesh:

Substances:

Year:  2017        PMID: 28451877     DOI: 10.1007/s11154-017-9417-0

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  191 in total

1.  Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α.

Authors:  Yumie Aoshima; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Ai Nakazawa; Fumiko Kondo; Naoko Ono; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Nephrol Dial Transplant       Date:  2012-01-28       Impact factor: 5.992

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors:  Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

Review 4.  Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis.

Authors:  Sang Yhun Ju; Hyun Suk Jeong; Do Hoon Kim
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

Review 5.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  Vitamin D Promotes Protein Homeostasis and Longevity via the Stress Response Pathway Genes skn-1, ire-1, and xbp-1.

Authors:  Karla A Mark; Kathleen J Dumas; Dipa Bhaumik; Birgit Schilling; Sonnet Davis; Tal Ronnen Oron; Dylan J Sorensen; Mark Lucanic; Rachel B Brem; Simon Melov; Arvind Ramanathan; Bradford W Gibson; Gordon J Lithgow
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

7.  Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.

Authors:  M R Grübler; M Gaksch; K Kienreich; N D Verheyen; J Schmid; C Müllner; G Richtig; H Scharnagl; C Trummer; V Schwetz; A Meinitzer; B Pieske; W März; A Tomaschitz; S Pilz
Journal:  J Steroid Biochem Mol Biol       Date:  2016-12-24       Impact factor: 4.292

8.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies.

Authors:  Armin Zittermann; Simona Iodice; Stefan Pilz; William B Grant; Vincenzo Bagnardi; Sara Gandini
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

Review 9.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

10.  Serum vitamin D levels correlate to coronary artery disease severity: a retrospective chart analysis.

Authors:  Robert Sogomonian; Hassan Alkhawam; JoshPaul Jolly; Neil Vyas; Sumair Ahmad; Emma Moradoghli Haftevani; Ahmed Al-Khazraji; Dennis Finkielstein; Timothy J Vittorio
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-26
View more
  30 in total

1.  New light on an old vitamin: The role of the sunshine vitamin D in chronic disease.

Authors:  Giovanna Muscogiuri
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

2.  New light on an old vitamin: The role of the sunshine vitamin D in chronic disease.

Authors:  Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

3.  Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Authors:  D Liu; L Chen; S Dong; Z Peng; H Yang; Y Chen; L Li; H Zhou; R Zhou
Journal:  Osteoporos Int       Date:  2019-06-10       Impact factor: 4.507

4.  Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials.

Authors:  JoAnn E Manson; Shari S Bassuk; Julie E Buring
Journal:  J Steroid Biochem Mol Biol       Date:  2019-11-13       Impact factor: 4.292

Review 5.  Vitamin D and regulation of vascular cell function.

Authors:  Nasim Jamali; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

6.  The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.

Authors:  Lise Sofie Bislev; Lene Langagergaard Rødbro; Jesper Nørgaard Bech; Erling Bjerregaard Pedersen; Alisa D Kjaergaard; Søren Andreas Ladefoged; Lars Rolighed; Tanja Sikjaer; Lars Rejnmark
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

7.  Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.

Authors:  JoAnn E Manson; Shari S Bassuk; Nancy R Cook; I-Min Lee; Samia Mora; Christine M Albert; Julie E Buring
Journal:  Circ Res       Date:  2020-01-02       Impact factor: 17.367

8.  Dietary Magnesium Intake Affects the Vitamin D Effects on HOMA-β and Risk of Pancreatic β-Cell Dysfunction: A Cross-Sectional Study.

Authors:  Rongpeng Gong; Yuanyuan Liu; Gang Luo; Lixin Yang
Journal:  Front Nutr       Date:  2022-03-29

Review 9.  The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?

Authors:  Shari S Bassuk; Paulette D Chandler; Julie E Buring; JoAnn E Manson
Journal:  Am J Lifestyle Med       Date:  2020-12-24

10.  Next Generation Sequencing of 502 Lifestyle and Nutrition related Genetic Polymorphisms reveals Independent Loci for Low Serum 25-hydroxyvitamin D Levels among Adult Respondents of the 2013 Philippine National Nutrition Survey.

Authors:  Mark Pretzel Zumaraga; Mae Anne Concepcion; Charmaine Duante; Marietta Rodriguez
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.